Sunshine Biopharma (SBFM) Operating Income Growth (3y) (2015 - 2026)
Sunshine Biopharma (SBFM) Operating Income Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 273.62% |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 3.84% |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -59.82% |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 4.63% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | -30.05% |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 54.58% |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 40.17% |
| 10 | Sunshine Biopharma | 750,608.81 | -6.16 Mn | 2.18 Mn | 8.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.62% |
| Dec 31, 2025 | 57.53% |
| Sep 30, 2025 | 14.16% |
| Jun 30, 2025 | -43.47% |
| Mar 31, 2025 | -1.93% |
| Dec 31, 2024 | -93.87% |
| Sep 30, 2024 | -30.64% |
| Jun 30, 2024 | -48.33% |
| Mar 31, 2024 | -1.92% |
| Dec 31, 2023 | -51.22% |
| Sep 30, 2023 | -126.27% |
| Jun 30, 2023 | -99.04% |
| Mar 31, 2023 | -264.72% |
| Dec 31, 2022 | -353.45% |
| Sep 30, 2022 | -103.91% |
| Jun 30, 2022 | -119.05% |
| Mar 31, 2022 | -115.52% |
| Dec 31, 2021 | -24.84% |
| Sep 30, 2021 | -19.77% |
| Jun 30, 2021 | 12.52% |